Apotex Health priced its upsized initial public offering at the C$24 top end on Tuesday, June 9, raising C$1.3 billion in gross proceeds. The healthcare provider in Canada sold 54.17 million common shares after increasing the offering size to meet investor demand. The pricing at the peak of the range suggests a robust appetite for pharmaceutical listings as the firm prepares for its public debut.

Strong Demand Drives Upsized Offering